HRCT for Tuberculosis Diagnosis

Primary Imaging Approach

The American College of Radiology recommends chest radiography as the first-line imaging test for tuberculosis diagnosis, with HRCT reserved for specific clinical scenarios where chest radiography is equivocal, nondiagnostic, or when patients are at high risk with negative initial imaging 1, 2
Chest radiography should be performed first in all patients with suspected active tuberculosis, as it has high sensitivity for detecting manifestations of active TB, according to the American College of Radiology 1, 3
The European standards for tuberculosis care emphasize that all persons with chest radiographic findings suggestive of pulmonary tuberculosis should have sputum specimens submitted for bacteriological confirmation, positioning chest radiography as the initial imaging modality 4, 5

Immunocompromised patients, particularly those with AIDS and very low CD4 counts, who may have deceptively normal chest radiographs despite active disease, may benefit from HRCT 1, 2, 3
Patients on anti-tumor necrosis factor medications with high clinical suspicion for active TB and unrevealing chest radiography may benefit from HRCT 1, 3
Acid-fast bacilli smear-negative patients at high risk may benefit from CT to increase diagnostic specificity 1, 3
CT is appropriate when tuberculosis is suspected but chest radiography findings are equivocal or nondiagnostic 1, 3
The major advantage of CT is increasing the specificity of TB diagnosis by better demonstrating cavitation, endobronchial spread with tree-in-bud nodules, and subtle parenchymal disease 6

Do not use HRCT as a first-line screening or diagnostic tool—this represents inappropriate resource utilization when chest radiography is adequate, according to the American College of Radiology 1, 3
In patients without clinical symptoms, even chest radiography has negligible yield for active TB that would change management 2, 3
CT should be reserved for rare cases where chest radiography is equivocal for active TB or when knowledge of disease extent is needed for specific clinical decisions (e.g., solid organ transplantation, biologic therapy) 2, 3
The diagnostic algorithm prioritizes bacteriological confirmation over imaging: All imaging findings must be complemented by WHO-recommended rapid molecular testing, culture, and drug susceptibility testing in quality-assured laboratories 4, 5